BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 1457721)

  • 1. Production of monoclonal antibody in hollow fiber culture system with serum-free medium.
    Zhou W; Cai S
    Chin J Biotechnol; 1992; 8(1):41-9. PubMed ID: 1457721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibody production in hollow fiber bioreactors using serum-free medium.
    Heifetz AH; Braatz JA; Wolfe RA; Barry RM; Miller DA; Solomon BA
    Biotechniques; 1989 Feb; 7(2):192-9. PubMed ID: 2629847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new serum-free medium for monoclonal antibody production.
    Wolfe RA; Braatz JA; Miller DA; Heifetz AH
    Biotechniques; 1988 Jan; 6(1):62-7. PubMed ID: 3273394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medium-scale production and purification of monoclonal antibodies in protein-free medium.
    Tarleton RL; Beyer AM
    Biotechniques; 1991 Nov; 11(5):590-3. PubMed ID: 1804247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum preparation and methods for the large-scale production of IgG monoclonal antibody.
    Zeng QS; Takeyama H; Kanda S; Irie RF
    Hum Antibodies Hybridomas; 1994; 5(1-2):75-80. PubMed ID: 7858185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors affecting monoclonal antibody production in culture.
    Reuveny S; Velez D; Macmillan JD; Miller L
    Dev Biol Stand; 1987; 66():169-75. PubMed ID: 3582746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous production of monoclonal antibody in a packed-bed bioreactor.
    Golmakany N; Rasaee MJ; Furouzandeh M; Shojaosadati SA; Kashanian S; Omidfar K
    Biotechnol Appl Biochem; 2005 Jun; 41(Pt 3):273-8. PubMed ID: 15506916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of monoclonal antibodies in culture.
    Reuveny S; Velez D; Riske F; MacMillan JD; Miller L
    Dev Biol Stand; 1985; 60():185-97. PubMed ID: 3930316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perfusion culture of hybridoma cells for hyperproduction of IgG(2a) monoclonal antibody in a wave bioreactor-perfusion culture system.
    Tang YJ; Ohashi R; Hamel JF
    Biotechnol Prog; 2007; 23(1):255-64. PubMed ID: 17269696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pilot-scale production of murine monoclonal antibodies in agitated, ceramic-matrix or hollow-fiber cell culture systems.
    Kurkela R; Fraune E; Vihko P
    Biotechniques; 1993 Oct; 15(4):674-83. PubMed ID: 8251170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction of hybridomas secreting monoclonal antibody against sweet potato feathery mottle virus and use of antibody for detection of SPFMV.
    Li R; Xue A; Zhu X; Cai S
    Chin J Biotechnol; 1992; 8(4):277-81. PubMed ID: 1343832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hybridoma cell growth and monoclonal antibody yield in serum-free media.
    Simonson L; Morton H; Reedy E
    Cytobios; 1994; 77(310):159-65. PubMed ID: 8020250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Production of monoclonal antibodies in serum-free medium in dialysis tubing].
    Witt S; Ziegler B; Blumentritt C; Schlosser M; Ziegler M
    Allerg Immunol (Leipz); 1991; 37(2):67-74. PubMed ID: 1801593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On-line purification of monoclonal antibodies using an integrated stirred-tank reactor/expanded-bed adsorption system.
    Ohashi R; Otero JM; Chwistek A; Yamato I; Hamel JF
    Biotechnol Prog; 2002; 18(6):1292-300. PubMed ID: 12467465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Continuous production of anti-hepatitis B surface antigen monoclonal antibody in hollow fiber perfusion bioreactor].
    Meng MH; Chen GC; Hsieh JH; Yueh Y; Chen SC; Chang TH; Tsao D
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1988 Aug; 21(3):125-40. PubMed ID: 3072154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of the Centritech Lab centrifuge for perfusion culture of hybridoma cells in protein-free medium.
    Johnson M; Lanthier S; Massie B; Lefebvre G; Kamen AA
    Biotechnol Prog; 1996; 12(6):855-64. PubMed ID: 8983210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Large-scale production of monoclonal antibodies in defined serum-free media in airlift bioreactors.
    Petrossian A; Cortessis GP
    Biotechniques; 1990 Apr; 8(4):414-22. PubMed ID: 2340179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A perfusion system for high productivity of monoclonal antibody by hybridoma cells in a CelliGen bioreactor.
    Chen Y
    Chin J Biotechnol; 1992; 8(3):179-86. PubMed ID: 1295598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A perfusion culture system using a stirred ceramic membrane reactor for hyperproduction of IgG2a monoclonal antibody by hybridoma cells.
    Dong H; Tang YJ; Ohashi R; Hamel JF
    Biotechnol Prog; 2005; 21(1):140-7. PubMed ID: 15903251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A serum independent medium effective in all aspects of hybridoma technology and immunological applications.
    Baker P; Knoblock K; Noll L; Wyatt D; Lydersen B
    Dev Biol Stand; 1985; 60():63-72. PubMed ID: 3876250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.